Catherine Soubie

Medica SA operates as a holding company, which provides long-term care nursing homes, rehabilitation & recuperative care and short-term psychiatric care services. The company operates through two segments: Long-Term Care and Post-Acute and Psychiatric Care. The Long-Term Care segment comprises of nursing and residential care homes for the dependent elderly in France. The Post-Acute and Psychiatric Care segment provides short-term post-operative rehabilitation care and also psychiatric services. The company was founded by Pierre Burel in 1968 and is headquartered in Paris, France.

Barclays Capital SAS provides brokerage services. The company is based in Paris, France.

Morgan Stanley (France) SAS provides brokerage services. The company was founded in 1935 and is headquartered in Paris, France.

Arfilia SAS operates as a holding company. The company was founded on September 13, 2005 and is headquartered in Paris, France.

Sofina SAS operates as a holding company with interest in providing business management services. The company was founded in 1981 and is headquartered in Paris, France.

Alixio SAS provides business consulting services. It also offers solutions in management changes, restructuring, mergers and acquisitions, digital transformation, and coaching. The company was founded by Raymond Soubie and Thierry Virol in 2010 and is headquartered in Paris, France.

Taddeo is a French company that offers public relations and communication consulting services. The company is based in Paris, France.

Sofina SA is a traded investment company invest in both private and listed companies located in North America, Asia Pacific and Europe primarily in Western Europe, India, China and the United States. It targets companies operating in the fields of digital transformation, consumer & retail, education, healthcare, energy and services, e-commerce, consumer goods, digital, satellite operations, industry, finance companies, financial services, media, communications, insurance, property development and life sciences. It provides financing for early stage, later stage, buyout and growth capital requirements with an investment size of €5 to €300 million. It acts as a lead investor, considers co-investments and takes a minority interest.